The impact of CPAP on cardiovascular biomarkers in minimally symptomatic patients with obstructive sleep apnea: A pilot feasibility randomized crossover trial

Lung

Volumn 187, Issue 1, 2009, Pages 17-22

  Comondore, Vikram R ^a   Cheema, Rupi ^a   Fox, Joel ^a   Butt, Arsalan ^a   John Mancini, G B ^a   Fleetham, John A ^a   Ryan, C Frank ^a   Chan, Sammy ^a   Ayas, Najib T ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Gordon and Leslie Diamond Health Care Centre Vancouver Coastal Health   (Canada)

Author keywords

Blood pressure; Cardiovascular risk; Continuous positive pressure ventilation; Diabetes; Dyslipidemia; Endothelial function; Hypopnea; Obstructive sleep apnea

Indexed keywords

ADRENALIN; ALBUMIN; BIOCHEMICAL MARKER; C REACTIVE PROTEIN; CATECHOLAMINE; CREATININE; FIBRINOGEN; GLUCOSE; GLYCERYL TRINITRATE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; HOMOCYSTEINE; INSULIN; LOW DENSITY LIPOPROTEIN; NORADRENALIN; TRIACYLGLYCEROL;

ADULT; APNEA; ARTERY DILATATION; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE; BODY MASS; BRACHIAL ARTERY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIABETES MELLITUS; DISEASE SEVERITY; DYSLIPIDEMIA; EPWORTH SLEEPINESS SCALE; FEMALE; HUMAN; INSULIN RESISTANCE; LABORATORY TEST; MALE; MICROALBUMINURIA; PATIENT COMPLIANCE; PILOT STUDY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SLEEP APNEA SYNDROME; TREATMENT OUTCOME; ULTRASOUND; URINE LEVEL; VASCULAR ENDOTHELIUM;

ALBUMINURIA; BIOLOGICAL MARKERS; BLOOD PRESSURE; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CATECHOLAMINES; CONTINUOUS POSITIVE AIRWAY PRESSURE; CROSS-OVER STUDIES; EPINEPHRINE; FEMALE; HUMANS; LIPIDS; MALE; MIDDLE AGED; NOREPINEPHRINE; PILOT PROJECTS; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE;

EID: 58249118943     PISSN: 03412040     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00408-008-9115-5     Document Type: Article

References (28)

1. T Young M Palta J Dempsey J Skatrud S Weber S Badr 1993 The occurrence of sleep-disordered breathing among middle-aged adults N Engl J Med 32 1230 1235 10.1056/NEJM199304293281704
2. M Ip KF Chung KN Chan SP Lam K Lee 1999 Previously unrecognized obstructive sleep apnea in Chinese subjects with essential hypertension Lung 177 6 391 400 10.1007/PL00007656
3. N AlGhanim V Comondore NT Ayas 2008 The economic impact of obstructive sleep apnea Lung 186 7 12 10.1007/s00408-007-9055-5
4. JM Marin SJ Carrizo E Vincente AG Agusti 2005 Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnea with or without treatment with continuous positive airway pressure: an observational study Lancet 365 1046 1053
5. I Szollosi H Krum D Kaye MT Naughton 2007 Sleep apnea in heart failure increases heart rate variability and sympathetic dominance Sleep 30 1 1509 1514
6. AS Shamsuzzaman M Winnicki P Lanfranchi R Wolk T Kara V Accurso VK Somers 2002 Elevated C-reactive protein in patients with obstructive sleep apnea Circulation 105 21 2462 2464 10.1161/01.CIR.0000018948.95175.03
7. M Kato P Roberts-Thomson BG Phillips WG Haynes M Winnicki V Accurso VK Somers 2000 Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea Circulation 102 21 2607 2610
8. C Zamarron J Ricoy A Riveiro F Gude 2008 Plasminogen activator inhibitor 1 in obstructive sleep apnea patients with and without hypertension Lung 186 3 151 156
9. R Budhiraja S Parthasarathy SF Quan 2007 Endothelial dysfunction in obstructive sleep apnea J Clin Sleep Med 3 4 409 415
10. J Fleetham N Ayas D Bradley K Ferguson M Fitzpatrick C George P Hanly F Hill J Kimoff M Kryger D Morrison F Series W Tsai CTS Sleep Disordered Breathing Committee 2006 Canadian Thoracic Society Guidelines: Diagnosis and treatment of sleep disordered breathing in adults Can Respir J 13 7 387 392
11. SR Patel DP White A Malhotra ML Stanchina NT Ayas 2003 Continuous positive airway pressure therapy for treating sleepiness in a diverse population with obstructive sleep apnea: results of a meta-analysis Arch Intern Med 163 565 571 10.1001/archinte.163.5.565
12. AT Mulgrew N Fox NT Ayas CF Ryan 2007 Diagnosis and initial management of OSA without polysomnography: A randomized validation study Ann Intern Med 146 157 166
13. SY Chan GB Mancini L Kuramoto M Schulzer J Frohlich A Ignaszewski 2003 The prognostic importance of endothelial dysfunction and carotid atheroma burden in patients with coronary artery disease J Am Coll Cardiol 42 6 1037 1043 10.1016/S0735-1097(03)00927-6
14. Rosner B (1995) Fundamentals of Biostatistics, 4th edn. Duxbury Press, Boston, MA, pp 564-565
15. HF Becker A Jerrentrup T Ploch L Grote T Penzel CE Sullivan JH Peter 2003 Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea Circulation 107 1 68 73 10.1161/01.CIR.0000042706.47107.7A
16. F Campos-Rodriguez A Grilo-Reina J Perez-Ronchel M Merino-Sanchez MA Gonzalez-Benitez M Beltran-Robles C Almeida-Gonzalez 2006 Effect of continuous positive airway pressure on ambulatory BP in patients with sleep apnea and hypertension: a placebo-controlled trial Chest 129 6 1457 1467 10.1378/chest.129.6.1459
17. M Alajmi AT Mulgrew J Fox W Davidson M Schulzer E Mak CF Ryan J Fleetham P Choi NT Ayas 2007 Impact of CPAP therapy on blood pressure in patients with OSAH A meta-analysis of RCT. Lung 185 67 72 10.1007/s00408-006-0117-x
18. P Haentjens A Van Meerhaeghe A Moscariello S De Weerdt K Poppe A Dupont B Velkeniers 2007 The impact of CPAP on blood pressure in patients with obstructive sleep apnea syndrome Arch Intern Med 167 757 764 10.1001/archinte.167.8.757
19. PM Ridker 2003 High-sensitivity C-reactive protein and cardiovascular risk: rationale for screening and primary prevention Am J Cardiol 92 4B 17K 22K 10.1016/S0002-9149(03)00774-4
20. T Yokoe K Minoguchi H Matsuo N Oda H Minoguchi G Yoshino T Hirano M Adachi 2003 Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure Circulation 107 8 1129 1134 10.1161/01.CIR.0000052627.99976.18
21. A Barcelo F Barbe E Llompart LR Mayoralas A Ladaria M Bosch AG Agustí 2004 Effects of obesity on C-reactive protein level and metabolic disturbances in male patients with obstructive sleep apnea Am J Med 117 2 118 121 10.1016/j.amjmed.2004.01.025
22. J Li LN Thorne NM Punjabi CK Sun AR Schwartz PL Smith RL Marino A Rodriguez WC Hubbard CP O'Donnell VY Polotsky 2005 Intermittent hypoxia induces hyperlipidemia in lean mice Circ Res 97 698 10.1161/01.RES.0000183879.60089.a9
23. GV Robinson JC Pepperell HC Segal RJ Davies JR Stradling 2004 Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials Thorax 59 9 777 782 10.1136/thx.2003.018739
24. NM Punjabi JD Sorkin LI Katzel AP Goldberg AR Schwartz PL Smith 2002 Sleep-disordered breathing and insulin resistance in middle-aged and overweight men Am J Respir Crit Care Med 165 677 682
25. IA Harsch SP Schahin M Radespiel-Troger O Weintz H Jahreiss FS Fuchs GH Wiest EG Hahn T Lohmann PC Konturek JH Ficker 2004 Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome Am J Respir Crit Care Med 169 2 156 162 10.1164/rccm.200302-206OC
26. SD West DJ Nicoll 2007 The effect of CPAP on insulin resistance and HbA1C in men with OSA and type 2 diabetes Thorax 62 11 969 974
27. P Steiropoulos V Tsara E Nena C Fitili M Kataropoulou M Froudarakis P Christaki D Bouros 2008 Effect of continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome Chest 132 3 843 851
28. GV Robinson DM Smith BA Langford RJ Davies JR Stradling 2006 CPAP does not reduce blood pressure in non-sleepy hypertensive OSA patients Eur Respira J 27 1229 1235